ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript February 28, 2024
ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.02. ADMA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon. And welcome to the ADMA Biologics Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Wednesday, February 28, 2024. At...
